Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Descriptive baseline characteristics by dietary acrylamide intake Parameter | T1†(n = 1488) | T2†(n = 1485) | T3†(n = 1463) | p-value*: Vitamin D (UI) (mean, SD) | 146 (112) | 137 (103) | 142 (108) | 0.06
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
Source: Article title.
Potential participants were included from 4 different sites in the United States of America (Baltimore, MD; Pittsburgh, PA; Pawtucket, RI; and Columbus, OH) between February 2004 and May 2006.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
Cohort study · Aging Clinical and Experimental Research · 2022
Original publication title
Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To investigate if dietary acrylamide is associated with the onset of fractures in North American participants at high risk/having knee osteoarthritis (OA), over 8 years of follow-up.
Source: AimsAbstract: What methods does the paper describe?
A Cox’s regression analysis, adjusted for baseline confounders was run and the data were reported as hazard ratios (HRs) and 95% confidence intervals (CIs). Dietary acrylamide intake was assessed at the baseline using a food frequency questionnaire and categorized in tertiles (T), whilst fractures’ history was recorded using self-reported information.
Source: MethodsAbstract: Results
Altogether, 4,436 participants were included. Compared to participants with lower acrylamide intake (T1; < 3,313 μg), those with a higher acrylamide intake (T3; > 10,180 μg) reported a significantly higher risk of any fracture (HR = 1.37; 95% CI 1.12 to 1.68; p for trend = 0.009), forearm (HR = 1.73; 95% CI 1.09 to 2.77; p for trend = 0.04), spine (HR = 2.21; 95% CI 1.14 to 4.31; p for trend = 0.04), and hip fracture (HR = 4.09; 95% CI 1.29 to 12.96; p for trend = 0.046).
Source: ResultsAbstract: Conclusions
Our study is the first to report that high dietary acrylamide may be associated with an increased risk of osteoporotic fractures.
Source: ConclusionsAuthors’ abstract
Background
Acrylamide, a component of fried foods, has been associated with several negative health outcomes. However, the relationship between dietary acrylamide and osteoporotic fractures has been explored by a few cross-sectional studies.
Aims
To investigate if dietary acrylamide is associated with the onset of fractures in North American participants at high risk/having knee osteoarthritis (OA), over 8 years of follow-up.
Methods
A Cox’s regression analysis, adjusted for baseline confounders was run and the data were reported as hazard ratios (HRs) and 95% confidence intervals (CIs). Dietary acrylamide intake was assessed at the baseline using a food frequency questionnaire and categorized in tertiles (T), whilst fractures’ history was recorded using self-reported information.
Results
Altogether, 4,436 participants were included. Compared to participants with lower acrylamide intake (T1; < 3,313 μg), those with a higher acrylamide intake (T3; > 10,180 μg) reported a significantly higher risk of any fracture (HR = 1.37; 95% CI 1.12 to 1.68; p for trend = 0.009), forearm (HR = 1.73; 95% CI 1.09 to 2.77; p for trend = 0.04), spine (HR = 2.21; 95% CI 1.14 to 4.31; p for trend = 0.04), and hip fracture (HR = 4.09; 95% CI 1.29 to 12.96; p for trend = 0.046).
Conclusions
Our study is the first to report that high dietary acrylamide may be associated with an increased risk of osteoporotic fractures.
Publication and source details
Original title: Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
Nicola Veronese; Francesco Bolzetta; Chiara Cacco; Alberto Cester; Lee Smith; Jacopo Demurtas; Cyrus Cooper; Renè Rizzoli; Maria Gabriella Caruso; Maria Notarnicola; Jean-Yves Reginster; Stefania Maggi; Mario Barbagallo; Mike Trott; Ligia J. Dominguez
Aging Clinical and Experimental Research · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Università degli Studi di PalermoOpen access funding provided by Università degli Studi di Palermo within the CRUI-CARE Agreement.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T07:59:30.105500+00:00
DOI: 10.1007/s40520-022-02214-9 · PMC9637630